170 related articles for article (PubMed ID: 3424219)
1. Structure-toxicity relationships of the tetramethylated tetralin and indane analogs of retinoic acid.
Howard WB; Willhite CC; Sharma RP
Teratology; 1987 Dec; 36(3):303-11. PubMed ID: 3424219
[TBL] [Abstract][Full Text] [Related]
2. Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).
Flanagan JL; Willhite CC; Ferm VH
J Natl Cancer Inst; 1987 Mar; 78(3):533-8. PubMed ID: 3469465
[TBL] [Abstract][Full Text] [Related]
3. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
Elmazar MM; Reichert U; Shroot B; Nau H
Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
[TBL] [Abstract][Full Text] [Related]
4. Analysis of high dysmorphogenic activity of Ro 13-6307, a tetramethylated tetralin analog of retinoic acid.
Kochhar DM; Penner JD
Teratology; 1992 Jun; 45(6):637-45. PubMed ID: 1412056
[TBL] [Abstract][Full Text] [Related]
5. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
Willhite CC; Lovey A; Eckhoff C
Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of retinoids in developmental toxicology. III. Contribution of the vitamin A beta-cyclogeranylidene ring.
Howard WB; Willhite CC; Dawson MI; Sharma RP
Toxicol Appl Pharmacol; 1988 Aug; 95(1):122-38. PubMed ID: 3413791
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of retinoids in developmental toxicology. II. Influence of the polyene chain of the vitamin A molecule.
Willhite CC
Toxicol Appl Pharmacol; 1986 May; 83(3):563-75. PubMed ID: 3705076
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of embryotoxicity by structural modification of the terminal group of cancer chemopreventive retinoids.
Willhite CC; Shealy YF
J Natl Cancer Inst; 1984 Mar; 72(3):689-95. PubMed ID: 6583452
[TBL] [Abstract][Full Text] [Related]
9. Retinamides: hydrolytic conversion of retinoylglycine to retinoic acid in pregnant mice contributes to teratogenicity.
Kochhar DM; Shealy YF; Penner JD; Jiang H
Teratology; 1992 Feb; 45(2):175-85. PubMed ID: 1615427
[TBL] [Abstract][Full Text] [Related]
10. Comparative disposition, receptor affinity, and teratogenic activity of sulfon arotinoids.
Willhite CC; Dubois A; Schindler-Horvat J; Apfel C; Eckhoff C
Teratology; 1995 Sep; 52(3):169-75. PubMed ID: 8638257
[TBL] [Abstract][Full Text] [Related]
11. Teratogenicity of all-trans retinoic acid during early embryonic development in the cynomolgus monkey (Macaca fascicularis).
Hendrickx AG; Hummler H
Teratology; 1992 Jan; 45(1):65-74. PubMed ID: 1731397
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of retinoids in developmental toxicology. IV. Planar Cisoid conformational restriction.
Willhite CC; Dawson MI
Toxicol Appl Pharmacol; 1990 Apr; 103(2):324-44. PubMed ID: 2330592
[TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits.
Tembe EA; Honeywell R; Buss NE; Renwick AG
Toxicol Appl Pharmacol; 1996 Dec; 141(2):456-72. PubMed ID: 8975771
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of retinoids in hamster tracheal organ culture.
Newton DL; Henderson WR; Sporn MB
Cancer Res; 1980 Oct; 40(10):3413-25. PubMed ID: 6159964
[TBL] [Abstract][Full Text] [Related]
15. Induction of RAR-beta 2 gene expression in embryos and RAR-beta 2 transactivation by the synthetic retinoid Ro 13-6307 correlates with its high teratogenic potency.
Soprano DR; Tairis N; Gyda M; Harnish DC; Jiang H; Soprano KJ; Kochhar DM
Toxicol Appl Pharmacol; 1993 Sep; 122(1):159-63. PubMed ID: 8397452
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic assessment of teratologically effective concentrations of an endogenous retinoic acid metabolite.
Satre MA; Penner JD; Kochhar DM
Teratology; 1989 Apr; 39(4):341-8. PubMed ID: 2749577
[TBL] [Abstract][Full Text] [Related]
17. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
Collins MD; Tzimas G; Hummler H; Bürgin H; Nau H
Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
[TBL] [Abstract][Full Text] [Related]
18. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
[TBL] [Abstract][Full Text] [Related]
19. Teratogenicity of low doses of all-trans retinoic acid in presomite mouse embryos.
Sulik KK; Dehart DB; Rogers JM; Chernoff N
Teratology; 1995 Jun; 51(6):398-403. PubMed ID: 7502239
[TBL] [Abstract][Full Text] [Related]
20. Teratogenic dose-response relationships of etretinate in the golden hamster.
Williams KJ; Ferm VH; Willhite CC
Fundam Appl Toxicol; 1984 Dec; 4(6):977-82. PubMed ID: 6519378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
